Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson’s disease by inhibiting oxidative stress and neuroinflammation
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09852-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Mulan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Growth, Development, and Mental Health of Children and Adolescence Center, Pediatric Research Institute, Ministry of Education Key Laboratory of Chil…. Hauptthemen laut MEDLINE: Oxidative Stress, Disease Models, Animal, Neuroprotective Agents, Chalcones. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing, National Natural Science Foundation of China, CQMU Program for Youth Innovation in Future Medicine.
Abstract (Originalsprache)
BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by oxidative stress and neuroinflammation. Sofalcone (SFC), a chalcone derivative known for its antioxidative and anti-inflammatory properties, is widely used clinically as a gastric mucosa protective agent. However, its therapeutic potential in PD remains to be fully explored. In this study, we investigated the neuroprotective effects of SFC in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. METHODS AND RESULTS: We found that SFC ameliorated MPTP-induced motor impairments in mice, as assessed by the rotarod and wire tests. Moreover, SFC administration prevented the loss of dopaminergic neurons and striatal degeneration induced by MPTP. Subsequent investigations revealed that SFC reversed MPTP-induced downregulation of NRF2, reduced elevated levels of reactive oxygen species (ROS) and malondialdehyde (MDA), and increased total antioxidant capacity (TAOC). Furthermore, SFC suppressed MPTP-induced activation of microglia and astrocytes, downregulated the pro-inflammatory cytokine TNF-α, and upregulated the anti-inflammatory cytokine IL-4. Additionally, SFC ameliorated the MPTP-induced downregulation of phosphorylation of Akt at Ser473. CONCLUSIONS: This study provides evidence for the neuroprotective effects of SFC, highlighting its antioxidative and anti-inflammatory properties and its role in Akt activation in the PD model. These findings underscore SFC's potential as a promising therapeutic candidate for PD, warranting further clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Growth, Development, and Mental Health of Children and Adolescence Center, Pediatric Research Institute, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Chi…
Förderung
- Natural Science Foundation of Chongqing
- National Natural Science Foundation of China
- CQMU Program for Youth Innovation in Future Medicine
Zitieren
APA
Chen, M., He, X., Fan, Y., Xia, L., & Dong, Z. (2024). Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson’s disease by inhibiting oxidative stress and neuroinflammation. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09852-4
Vancouver
Chen M, He X, Fan Y, Xia L, Dong Z. Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson’s disease by inhibiting oxidative stress and neuroinflammation. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09852-4
BibTeX
@article{Chen2024,
author = {Chen, Mulan and He, Xin and Fan, Yepeng and Xia, Lei and Dong, Zhifang},
title = {Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson’s disease by inhibiting oxidative stress and neuroinflammation},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09852-4}
}
EUVIMED